Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis
David A. Palma, Suresh Senan, Kayoko Tsujino et al. · International Journal of Radiation Oncology*Biology*Physics · 2013
Cited by 674 works. doi:10.1016/j.ijrobp.2012.04.043 Open-access PDF
Authors
- David A. Palma
- Suresh Senan
- Kayoko Tsujino
- Robert Bryan Barriger
- Ramesh Rengan
- Marta Moreno
- Jeffrey D. Bradley
- Tae Hyun Kim
- Sara Ramella
- Lawrence Bruce Marks
- Luigi De Petris
- Larry Stitt
- George Rodrigues
References
- Radiation Dose–Volume Effects in the Lung
- Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis
- Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer
- Prediction of radiation pneumonitis by dose–volume histogram parameters in lung cancer—a systematic review
- Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105
- A Phase I/II Radiation Dose Escalation Study With Concurrent Chemotherapy for Patients With Inoperable Stages I to III Non-Small-Cell Lung Cancer: Phase I Results of RTOG 0117
- A Nomogram to Predict Radiation Pneumonitis, Derived From a Combined Analysis of RTOG 9311 and Institutional Data
- Dose-volumetric Parameters for Predicting Severe Radiation Pneumonitis after Three-dimensional Conformal Radiation Therapy for Lung Cancer
- Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis
- Dose–Volume Analysis of Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated With Concurrent Cisplatinum and Etoposide With or Without Consolidation Docetaxel